FDA NDC Directory · JSON-LD · Markdown

Divalproex Sodium

NDC 68001-474 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA079163
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsDIVALPROEX SODIUM (500 mg/1)
Marketing started20210120
Package count2

External sources

Source: openFDA. Public-domain (CC0).